TABLE 3.
T. cruzi sequences exhibiting characteristics of membrane-associated or secreted proteinsa
| NCBI accession no. | Selected ORF | PSORT localization (P value) | N-terminal signal sequence P value | GPI C/A site | GPI addition signal sequence |
|---|---|---|---|---|---|
| AI0810133 | 5′-3′ frame 2 | PM (0.6) | 0.75 | + | + |
| AQ910890 | 5′-3′ frame 1 | PM (0.6) | 1.0 | + | − |
| AW325178 | 3′-5′ frame 2 | PM (0.4) | 1.0 | − | + |
| AW325227 | 5′-3′ frame 2 | PM (0.6) | 0.75 | + | − |
| AW325291 | 3′-5′ frame 3 | PM (0.6) | 0.25 | + | − |
| AW329906 | 5′-3′ frame 3 | OS (0.3) | 1.0 | + | − |
| AW330105 | 5′-3′ frame 3 | PM (0.4) | 1.0 | + | − |
| AW330110 | 5′-3′ frame 3 | PM (0.6) | 1.0 | + | − |
| AW330132 | 3′-5′ frame 2 | PM (0.6) | 0.75 | + | − |
| AW330166 | 3′-5′ frame 1 | PM (0.9) | 1.0 | + | + |
| AW330173 | 5′-3′ frame 2 | PM (0.3) | 0.5 | + | − |
| AW330187 | 5′-3′ frame 1 | OS (0.8) | 0.75 | + | − |
| AW330209 | 5′-3′ frame 3 | PM (0.4) | 0.5 | + | + |
| AW330228 | 5′-3′ frame 2 | PM (0.7) | 0.75 | + | + |
| AW330247 | 3′-5′ frame 3 | PM (0.4) | 0.75 | + | + |
| AW330324 | 5′-3′ frame 1 | OS (0.8) | 1.0 | − | + |
| AW330353 | 3′-5′ frame 1 | PM (0.6) | 1.0 | + | + |
| AW330404 | 3′-5′ frame 2 | PM (0.6) | 0.0 | + | + |
| AZ050159 | 3′-5′ frame 1 | OS (0.8) | 1.0 | + | − |
As predicted by computational and bioinformatic analysis of EST and GSS databases. Localization of the encoded products to plasma membrane (PM) and outside (OS) was determined by PSORT analysis (probability score, 0 to 1). The presence of N-terminal signal sequence was assessed by SignalP (probability score, 0 to 1), the score of 1 being considered maximum for both PSORT and SignalP. The GPI cleavage-attachment (C/A) site of three amino acids (ω, ω + 1, ω + 2) and a GPI addition signal sequence in the C-terminal region of the ORF were predicted by DGPI. “+” and “−” signs represent the probability of the presence or absence, respectively, of a GPI C/A site or GPI addition signal.